The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Moriarty John B since 2015.
This trader's CIK number is 1564621.
At the time of last reporting, Moriarty John B was the Chief Legal Officer of Avidity Biosciences, Inc.. (stock ticker symbol RNA).
Also see all insider trading activities at Avidity Biosciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | RNA | 0 | $0 | 2,245 | $81,291 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | ALXN | 0 | $0 | 4,624 | $536,963 | 0 | $0 |
2017 | ALXN | 0 | $0 | 5,509 | $704,886 | 0 | $0 |
2016 | ALXN | 0 | $0 | 6,699 | $914,625 | 0 | $0 |
2015 | ALXN | 0 | $0 | 15,227 | $2,901,377 | 20,000 | $1,853,000 |
1. Avidity Biosciences, Inc. (RNA)
2. Alexion Pharmaceuticals, Inc. (ALXN)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-04 | RNA | Sale | 2,245 | 36.21 | 81,291 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-02-08 | ALXN | Sale | 3,363 | 115.70 | 389,099 |
2018-02-05 | ALXN | Sale | 1,261 | 117.26 | 147,864 |
2017-03-01 | ALXN | Sale | 282 | 132.50 | 37,365 |
2017-02-28 | ALXN | Sale | 910 | 131.71 | 119,856 |
2017-02-27 | ALXN | Sale | 612 | 131.20 | 80,294 |
2017-02-09 | ALXN | Sale | 167 | 126.84 | 21,182 |
2017-02-06 | ALXN | Sale | 3,403 | 126.03 | 428,897 |
2017-02-07 | ALXN | Sale | 135 | 128.09 | 17,292 |
2016-12-12 | ALXN | Sale | 1,044 | 118.61 | 123,828 |
2016-08-08 | ALXN | Sale | 135 | 137.14 | 18,513 |
2016-06-13 | ALXN | Sale | 918 | 135.72 | 124,590 |
2016-02-08 | ALXN | Sale | 2,633 | 138.75 | 365,328 |
2016-02-05 | ALXN | Sale | 1,969 | 143.41 | 282,366 |
2015-12-11 | ALXN | Sale | 943 | 184.09 | 173,601 |
2015-08-07 | ALXN | Sale | 135 | 190.01 | 25,651 |
2015-08-05 | ALXN | Sale | 10,010 | 198.59 | 1,987,835 |
2015-08-05 | ALXN | Option Ex | 20,000 | 92.65 | 1,853,000 |
2015-06-11 | ALXN | Sale | 914 | 170.00 | 155,380 |
2015-03-02 | ALXN | Sale | 280 | 180.34 | 50,495 |
2015-02-10 | ALXN | Sale | 1,490 | 171.15 | 255,013 |
2015-02-09 | ALXN | Sale | 1,455 | 174.16 | 253,402 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moriarty John B (Chief Legal Officer of Avidity Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.